Tommaso Marchetti
banner
tmarchetti.bsky.social
Tommaso Marchetti
@tmarchetti.bsky.social
Postdoc @ University of Zurich 🇨🇭
Adaptive immunity, cytokines and cytotoxicity
Pinned
The main part of my PhD work is published!

We found that targeted IL-2 therapy, instead of worsening HLH, improves disease by driving CD8 T cells into an exhaustion-like state, an immune brake we can harness to control inflammation, challenging the view that IL-2 only boosts CD8 T cell activity.
Selective IL-2 delivery modulates CD8+ T cells in human HLH and ameliorates disease features in a murine model
Primary hemophagocytic lymphohistiocytosis (HLH) is a severe inflammatory syndrome. In familial HLH, loss-of-function mutations in genes such as Prf1 disrupt perforin-dependent cytolysis, leading to s...
www.jacionline.org
Reposted by Tommaso Marchetti
We are hiring! 🧫 🧬 🚀

Three PhD studentships with start dates in 2026 available in the Molecular Mucosal Immunology lab at the Botnar Institute of Immune Engineering, Basel, Switzerland.

See here for details (Deadline: 7th November 2025):

join.com/companies/im...
Botnar Institute of Immune Engineering - BIIE (Zürich): Doctoral studentships, Molecular Mucosal Immunology Group
Botnar Institute of Immune Engineering - BIIE has a job opening for Doctoral studentships, Molecular Mucosal Immunology Group in Zürich (published: 29.10.2025). Apply now or check the other available...
join.com
October 29, 2025 at 12:51 PM
The main part of my PhD work is published!

We found that targeted IL-2 therapy, instead of worsening HLH, improves disease by driving CD8 T cells into an exhaustion-like state, an immune brake we can harness to control inflammation, challenging the view that IL-2 only boosts CD8 T cell activity.
Selective IL-2 delivery modulates CD8+ T cells in human HLH and ameliorates disease features in a murine model
Primary hemophagocytic lymphohistiocytosis (HLH) is a severe inflammatory syndrome. In familial HLH, loss-of-function mutations in genes such as Prf1 disrupt perforin-dependent cytolysis, leading to s...
www.jacionline.org
October 8, 2025 at 3:14 PM
Reposted by Tommaso Marchetti
Happy to share our work on the structure and function of the unusual E3 ligase ZNFX1 @cp-cell.bsky.social. It uses a nucleic acid-activated transthiolation mechanism, ubiquitinating and clustering RNA to protect cells in an immune response. @clausenlab.bsky.social
www.cell.com/cell/fulltex...
A split-site E3 ligase mechanism enables ZNFX1 to ubiquitinate and cluster single-stranded RNA into ubiquitin-coated nucleoprotein particles
Grabarczyk et al. show the structure and mechanism of a non-canonical ubiquitin ligase, which is activated through nucleic-acid-induced oligomerization and is critical for cell survival during immune ...
www.cell.com
August 27, 2025 at 7:04 PM
Reposted by Tommaso Marchetti
These are the most challenging times for early-career scientists and engineers.

My team is doing its bit to help by maintaining and even expanding our database of funding opportunities for early-career researchers.

We found 437 of them.

Download it freely here: research.jhu.edu/rdt/funding-...
August 11, 2025 at 11:54 AM
Reposted by Tommaso Marchetti
I am looking for a postdoc with an immunology background interested in joining a Yale neuroscience lab to study how the brain controls immunity. At Yale, we have a wonderful interdisciplinary & collaborative #neuroimmune community. Please reach out or share with anyone who might be interested!
May 22, 2025 at 11:42 AM
Reposted by Tommaso Marchetti
Reposted by Tommaso Marchetti
Our @natrevimmunol.bsky.social review with @abhishekgarglab.bsky.social, @deadoc80.bsky.social and Kellie Smith is out!

We attempt to integrate the data on CD8 T cell dysfunction into a new framework of hypofunctionality in cancer and chronic infections!

www.nature.com/articles/s41...
The diversity of CD8+ T cell dysfunction in cancer and viral infection - Nature Reviews Immunology
Beyond exhaustion, CD8+ T cells can adopt various dysfunctional states, including tolerant, anergic, senescent, ignorant and dying states, that compromise their ability to eradicate viruses or tumours...
www.nature.com
April 14, 2025 at 8:53 AM
Reposted by Tommaso Marchetti
A tour de force review of the connections between between the nervous and immune systems
www.nature.com/articles/s41...
February 12, 2025 at 4:29 PM
Reposted by Tommaso Marchetti
How did Cell, Nature & Science become the 3 hottest journals in biomedical research? You could call it 'The Curious Case of Benjamin Lewin’ & it's told in today's episode of the Night Science podcast with Keith Yamamoto (@kryamamoto.bsky.social ; starts at 15:00) @nightsciencepod.bsky.social ⬇️
January 28, 2025 at 1:13 AM
Reposted by Tommaso Marchetti
Cytokine-Induced Cell Exhaustion to Mitigate Hyperinflammation https://www.biorxiv.org/content/10.1101/2024.08.12.607544v1
Cytokine-Induced Cell Exhaustion to Mitigate Hyperinflammation https://www.biorxiv.org/content/10.1101/2024.08.12.607544v1
Haemophagocytic lymphohistiocytosis (HLH), a life-threatening hyperinflammatory disorder often drive
www.biorxiv.org
August 12, 2024 at 4:16 PM
Reposted by Tommaso Marchetti
Too often we spend only two weeks choosing a problem and then many years trying to solve it, but this limits our potential impact. For more listen to this really interesting @nightsciencepod.bsky.social episode!
Spotify: open.spotify.com/episode/6KMh...
Apple: podcasts.apple.com/us/podcast/n...
66 | Michael Fischbach and the scientific decision tree
Podcast Episode · Night Science · 11/25/2024 · 51m
podcasts.apple.com
November 25, 2024 at 9:51 PM
Reposted by Tommaso Marchetti
"We love interdisciplinary work! But..."
November 19, 2024 at 12:36 PM
Reposted by Tommaso Marchetti
Vive La France! 🇫🇷
July 7, 2024 at 8:28 PM
Reposted by Tommaso Marchetti
So much new on #longcovid. I've tried to pull it all together in a new Ground Truths
erictopol.substack.com/p/lighting-u...
January 19, 2024 at 10:05 PM